HLA-C and cutaneous melanoma: As already shown by our group and others, a decreased expression of several HLA class I APM components, such as TAP1, HLA-A, HLA-B and HLA-C, has been associated with poor patient survival in several types of cancer, including cutaneous melanoma [2,77,78,79,80].